Capstan Medical
Creating a new standard of heart valve treatment
Creating a new standard of heart valve treatment
Capstan Medical is a pioneering startup dedicated to revolutionizing the treatment of structural heart disease. The company's slogan, "Creating a new standard of heart valve treatment," aptly captures its mission. Founded in 2020 and headquartered in the United States, Capstan Medical has attracted significant attention in the investment landscape. Notably, the company secured a substantial $31.40M Series B investment on 09 August 2023, with prominent backers including Eclipse Ventures, Intuitive, Yu Galaxy, and Puma Venture Capital. With its innovative integration of surgical robotics, catheter-based technology, and next-generation implants, Capstan Medical is at the forefront of developing a patient-centric approach to heart valve repair and replacement. This strategic positioning, coupled with its recent investment success, underscores the company's potential for significant growth and impact within the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $31.40M | 4 |
|
09 Aug 2023 |
No recent news or press coverage available for Capstan Medical.
We care about your data, and we'd love to use cookies make your experience better.
